Macleods Pharma Usa Inc 2022-04-13 Health moderate FDA
Health · FDA · Recall #FDA-D-0762-2022
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for:… Recall
Issued April 13, 2022 · Macleods Pharma Usa Inc
In April 2022, Macleods Pharma Usa Inc recalled the Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for:…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
FAILED CONTENT UNIFORMITY SPECIFICATIONS
What you should do
- 1 Stop using Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Macleods Pharma Usa Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Macleods Pharma Usa Inc
- Category
- Health
- Recall date
- April 13, 2022
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0762-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Macleods Pharma Usa Inc has 6 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.